REGENPEP
Pharmaceuticals, namely, preparations for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity
Pending · May 24, 2024 · 98567742 ·